VVOS Return on Tangible Equity | Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (VVOS) Return on Tangible Equity

2026-06-30: Return Tang Equity 158.86%.
2026-03-31: Return Tang Equity 184.43%.
2025-12-31: Return Tang Equity 150.07%.
2025-09-30: Return Tang Equity 211.42%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	158.86%
2026-03-31	184.43%
2025-12-31	150.07%
2025-09-30	211.42%
2025-06-30	235.06%
2025-03-31	-931.76%
2024-12-31	-236.84%
2024-09-30	-283.13%
2024-06-30	-387.42%
2024-03-31	586.10%
2023-12-31	476.26%
2023-09-30	477.18%
2023-06-30	1586.63%
2023-03-31	-547.62%
2022-12-31	-1439.98%
2022-09-30	-375.37%
2022-06-30	-215.60%
2022-03-31	-124.38%
2021-12-31	-90.75%
2021-09-30	-65.40%
2021-06-30	-46.67%
2021-03-31	-113.27%
2020-12-31	-86.27%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	150.07%
2024-12-31	-236.84%
2023-12-31	476.26%
2022-12-31	-1439.92%
2021-12-31	-90.75%
2020-12-31	-86.27%
2019-12-31	170.61%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Beyond Air, Inc. (XAIR)	United States	$0.003B	-0.01
NEXGEL, INC. (NXGL)	United States	$0.002B
INVO Fertility, Inc. (IVF)	United States	$0.002B	-0.71
Catheter Precision, Inc. (VTAK)	United States	$0.002B	-0.23
Tenon Medical, Inc. (TNON)	United States	$0.002B
Autonomix Medical, Inc. (AMIX)	United States	$0.004B
Adagio Medical Holdings, Inc. (ADGM)	United States	$0.004B
Profusa, Inc. (PFSA)	United States	$0.002B
OSR Health, Inc. (OSRH)	United States	$0.004B	-0.75
Bluejay Diagnostics, Inc. (BJDX)	United States	$0.004B